NESTLE N 2L (NESNE.SW)
-Swiss | Prev Close: | N/A |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 49.50 - 49.50 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 0 |
|---|
| Market Cap: | N/A |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in CHF.
Headlines
- Nestle finds horse meat in beef pasta mealsAP(Tue, Feb 19)
- News Summary: Nestle sees challenges aheadAP(Thu, Feb 14)
- Nestle makes $11.55 billion profit in 2012AP(Thu, Feb 14)
- Pfizer Q4 net jumps on sale of nutrition businessAP(Tue, Jan 29)
- News Summary: Nutrition sale boosts Pfizer 4Q netAP(Tue, Jan 29)
- Earnings Preview: Pfizer to focus on new drug OKsAP(Fri, Jan 25)
- Unilever to phase out 'microplastics' by 2015AP(Thu, Dec 27)
- Pfizer 3Q profit falls 14 pct on generic LipitorAP(Thu, Nov 1)
- Pfizer 3Q report to focus on pipeline, new drugsAP(Fri, Oct 26)
- Nestle sales growth eases as global economy coolsAP(Thu, Oct 18)
- Emerging markets give Nestle a Q3 sales boostAP(Thu, Oct 18)
- Nestle posts 11 percent increase in 3Q salesAP(Thu, Oct 18)
- Pfizer files IPO plan for animal health businessAP(Mon, Aug 13)
- News Summary: Nestle posts higher first-half earnsAP(Thu, Aug 9)
- Nestle posts strong H1 profit but outlook is toughAP(Thu, Aug 9)
Reports
- No Reports available for NESNE.SW at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
No business summary available forNESNE.SW.
0.80%